(Q44987786)

8 December 2017

title

M1 receptor agonism, a possible treatment for cognitive deficits in schizophrenia (English)

1 reference

8 December 2017

0 references

1

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

8 December 2017

published in

Neuropsychopharmacology

1 reference

8 December 2017

volume

29

1 reference

8 December 2017

issue

8

1 reference

8 December 2017

page(s)

1583-4; author reply 1585-6

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300508

8 December 2017

exact match

0 references

cites work

Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300508

An open-labeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300508

Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300508

Muscarinic receptors in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300508

Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300508

Physostigmine and cognition in schizotypal personality disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300508

Association of muscarinic m1 receptor genetic polymorphisms with psychiatric symptoms and cognitive function in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300508

Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300508

Association of anticholinergic load with impairment of complex attention and memory in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300508

Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300508

In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300508

M1 Receptor Agonism, a Possible Treatment for Cognitive Deficits in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300508

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.NPP.1300508

1 reference

8 December 2017

1 reference